- Home
- IVDA vs CYCN Comparison
IVDA vs CYCN Comparison
Compare IVDA & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- CYCN
- Stock Information
- Founded
- IVDA 2003
- CYCN 2018
- Country
- IVDA United States
- CYCN United States
- Employees
- IVDA N/A
- CYCN N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- CYCN Health Care
- Exchange
- IVDA Nasdaq
- CYCN Nasdaq
- Market Cap
- IVDA 6.7M
- CYCN 6.5M
- IPO Year
- IVDA N/A
- CYCN N/A
- Fundamental
- Price
- IVDA $2.19
- CYCN $3.62
- Analyst Decision
- IVDA
- CYCN
- Analyst Count
- IVDA 0
- CYCN 0
- Target Price
- IVDA N/A
- CYCN N/A
- AVG Volume (30 Days)
- IVDA 78.5K
- CYCN 30.1K
- Earning Date
- IVDA 08-13-2025
- CYCN 08-06-2025
- Dividend Yield
- IVDA N/A
- CYCN N/A
- EPS Growth
- IVDA N/A
- CYCN N/A
- EPS
- IVDA N/A
- CYCN N/A
- Revenue
- IVDA $7,148,449.00
- CYCN $2,081,000.00
- Revenue This Year
- IVDA $340.48
- CYCN N/A
- Revenue Next Year
- IVDA N/A
- CYCN N/A
- P/E Ratio
- IVDA N/A
- CYCN N/A
- Revenue Growth
- IVDA 54.15
- CYCN N/A
- 52 Week Low
- IVDA $1.27
- CYCN $1.27
- 52 Week High
- IVDA $8.05
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- IVDA 51.25
- CYCN 63.94
- Support Level
- IVDA $1.76
- CYCN $2.95
- Resistance Level
- IVDA $2.44
- CYCN $3.73
- Average True Range (ATR)
- IVDA 0.18
- CYCN 0.33
- MACD
- IVDA 0.04
- CYCN 0.06
- Stochastic Oscillator
- IVDA 57.53
- CYCN 89.22
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.